Tech Company Financing Transactions

PierianDx Funding Round

PierianDx, based in St. Louis, received $47.5 million from OrbiMed, ATW Partners and Health Catalyst Capital Management.

Transaction Overview

Company Name
PierianDx
Announced On
11/3/2021
Transaction Type
Venture Equity
Amount
$47,500,000
Round
Undisclosed
Investors

OrbiMed (Lead Investor)

ATW Partners (Kerry Propper)

Health Catalyst Capital Management (Charles Boorady)

Inova Health System

Research Triangle Ventures

SJF Ventures

Proceeds Purpose
The new capital will drive commercial expansion in response to increased demand as more healthcare organizations seek to provide high quality, affordable, faster care locally to their patients by internalizing next generation sequencing (NGS) testing capabilities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
77 Maryland Plz.
St. Louis, MO 63108
USA
Phone
(314) 628-0035
Website
www.pieriandx.com
Email Address
[email protected]
Overview
PierianDx enables clinical labs to seamlessly manage and interpret complex genetic tests for the most effective patient care. For health systems, children's hospitals, comprehensive cancer centers and reference labs looking to bring next-generation sequencing in-house rapidly or one step at a time.
Profile
PierianDx LinkedIn Company Profile
Social Media
PierianDx Company Twitter Account
Company News
PierianDx News
Facebook
PierianDx on Facebook
YouTube
PierianDx on YouTube

Management Team

Title
Name
Email & Social
Chairman
Rakesh Nagarajan
  Rakesh Nagarajan LinkedIn Profile  Rakesh Nagarajan Twitter Account  Rakesh Nagarajan News  Rakesh Nagarajan on Facebook
Chief Executive Officer
Michael Sanderson
  Michael Sanderson LinkedIn Profile  Michael Sanderson Twitter Account  Michael Sanderson News  Michael Sanderson on Facebook
Chief Medical Officer
Shalini Verma
  Shalini Verma LinkedIn Profile  Shalini Verma Twitter Account  Shalini Verma News  Shalini Verma on Facebook
Chief Operating Officer
Chris Callahan
  Chris Callahan LinkedIn Profile  Chris Callahan Twitter Account  Chris Callahan News  Chris Callahan on Facebook
VP - Marketing
Josh Forsythe
  Josh Forsythe LinkedIn Profile  Josh Forsythe Twitter Account  Josh Forsythe News  Josh Forsythe on Facebook
VP - Product Management
Andrew Bredemeyer
  Andrew Bredemeyer LinkedIn Profile  Andrew Bredemeyer Twitter Account  Andrew Bredemeyer News  Andrew Bredemeyer on Facebook
VP - Product Management
Bryce Daines
  Bryce Daines LinkedIn Profile  Bryce Daines Twitter Account  Bryce Daines News  Bryce Daines on Facebook
VP - Product Management
Mukesh Sharma
  Mukesh Sharma LinkedIn Profile  Mukesh Sharma Twitter Account  Mukesh Sharma News  Mukesh Sharma on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/3/2021: First AML venture capital transaction
Next: 11/3/2021: Archive.ai venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.